Jincheng Pharmaceutical develops glutathione end market

Summary: On 3 June, 2016, Jincheng Pharmaceutical announced that its glutathione healthcare product "Yimeitai" has been under administrative review. If the company succeeds in obtaining Drug Production Certificate for this product, it will be the fir...

More from CCM

www.cnchemicals.com